The size of the global immunology market is projected to nearly double by 2032 to a quarter of a trillion dollars. Here are this year’s standout deals in the space.
ReutersRoche had paid $1.9 billion for New-York based Flatiron Health in 2018 to speed its development of cancer medicines and support its efforts to price them based on how well they work.
The agency has approved the French drugmaker’s treatment for a type of brain tumor, making it the first drug to get a U.S. approval for the condition.
Gene sequencing machine maker Illumina on Tuesday forecast 2024 sales from its core segment to decline, a sign that subdued demand for its instruments used in genetic tests could extend further into the year.
With ongoing technological advancements and the growing demand for improved healthcare solutions, digital therapeutics are poised to play an increasingly critical role in the future of medicine and digital health. However, achieving market access remains a major challenge due to regulatory and reimbursement complexities.
The industry veteran to retain role as president of PR, influence and social.